ARAKODA® (Tafenoquine)
Malaria Prophylaxis
ApprovedCommercial
Key Facts
About 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is a U.S.-based public biotech company (NASDAQ: SXTP) with a mission to develop and commercialize treatments for infectious diseases, particularly in the underserved tropical disease market. Its core achievement is the FDA approval and commercialization of ARAKODA® (tafenoquine) for malaria prophylaxis in adults, a product distinguished by its convenient weekly dosing. The company's strategy centers on the strategic repurposing and lifecycle management of tafenoquine for additional anti-infective indications while navigating the complex commercial and funding landscape of a micro-cap tropical disease biotech.
View full company profile